Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-11-24

FDA Approved: ZIAGEN — Supplemental Application (ViiV Healthcare Company)

View source ↗

Summary

FDA approved a supplemental application for Ziagen (abacavir sulfate) by ViiV Healthcare Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ziagen (Abacavir)

Snippet

SUPPL AP for ZIAGEN (ABACAVIR SULFATE)